Causation and prevention of solely estrogen-induced oncogenesis: Similarities to human ductal breast cancer

Advances in Experimental Medicine and Biology

Volumn 532, Issue , 2003, Pages 195-207

  Li, Jonathan J ^a   Li, Sara Antonia ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

BREAST CARCINOMA; CARCINOGENESIS; CONFERENCE PAPER; ESTRADIOL BLOOD LEVEL; EXPERIMENTAL RAT; MOLECULAR DYNAMICS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STEM CELL; SYRIAN HAMSTER; TUMOR MODEL;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0141868966     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0081-0_15     Document Type: Conference Paper

References (30)

1. Cancer statistics. Cancer J. Clin. 49:1-156 (1999).
2. Li, C.I., Weiss, N.S., Stanford, J.L., Daling J.R. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88:2570-2577 (2000).
3. King, M.C., Rowell, S., Love, S.M. Inherited breast cancer and ovarian cancer. What are the choices? J. Am. Med. Assoc. 269:175-180 (1993).
4. Gammon, M.D., Santella, R.M., Neugut, A.I., Eng, S.M., Teitelbaum, S.L., Paykin, A., Levin, B., Terry, M.B., Young, T.L., Wang, L.W., et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidem. Biomarkers & Prevent. 11:677-685 (2002).
5. Gammon, M.D., Wolff, M.S., Neugut, A.I., Eng, S.M., Teitelbaum, S.L., Britton, J.A., Terry, M.B., Levin, B., Sellman, S.D. Kabat, G.C., et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidem. Biomarkers & Prevent. 11:686-697 (2002).
6. Li, J.J., and S.A. Li. Breast cancer: Evidence for xenoestrogen involvement in altering its incidence and risk. In: Natural and Anthropogenic Environmental Oestrogens: The Scientific Basis for Risk Assessment. J. Pure & Appl. Chem. (IUPAC), 70:1713-1723 (1998).
7. Fisher B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Nat. Cancer Inst. 90:1371-1388 (1998).
8. Li, S.A., Xue, Y., Xie, Q., Li, C.I., Li, J.J. Serum and tissue levels of estradiol during estrogen-induced renal tumorigenesis in the Syrian hamster. J. Steroid Biochem. Molec. Biol. 48:283-286 (1994).
9. Li, S.A., Weroha, S.J., Tawfik, O., Li, J.J. Prevention of solely estrogen-induced mammary tumors by Tamoxifen: Evidence for estrogen receptor mediation. J. Endocrinol. 175:297-305 (2002).
10. Kirkman, H., Robbins, M. Histogenesis of estrogen-induced renal tumors in golden hamster. Anat. Res. 121:323 (1955).
11. Donten, W., Eder, M. Histogenese and biologische Verhaltenweise hormonell augeloster Geschwulste Beitr path. Anat. 120:270 (1959).
12. Llombart-Bosch, A., Peydro, A. Morphological, histochemical and ultrastructural observations of diethylstilbestrol-induced kidney tumors in the Syrian golden hamster. Europ. J. Cancer 11:403-412 (1975).
13. Gonzalez, A., Oberley, T.D., Li, J.J. Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: Probable cell of origin. Cancer Res. 49:1020-1028 (1989).
14. Oberley, T.D., Gonzalez, A., Lauchner, L.J., Oberley, L.W., Li, J.J. Characterization of early lesions in estrogen-induced renal tumors in the Syrian hamster. Cancer Res. 51:1922-1929 (1991).
15. Li, J.J., Weroha, S.J., Davis, M.F., Hou, X., Tawfik, O., Li, S.A. Estrogen and progesterone receptors in renomedullary interstitial cells during Syrian hamster estrogen-induced tumorigenesis: Evidence for receptor-mediated oncogenesis. Endocrinology 142:4006-4014 (2001).
16. Pelletier, G., Labrie, C., Labrie, F. Localization of oestrogen receptor, oestrogen receptor, and androgen receptors in the rat reproductive organs. J. Endocrinology 165:359-370 (2000).
17. Li, J.J., Cuthbertson, T.L., Li, S.A. Inhibition of estrogen carcinogenesis in the Syrian golden hamster kidney by antiestrogens. J. Nat. Cancer Inst. 64:795-800 (1980).
18. Kirkman H. Estrogen-induced tumors of the kidney in Syrian hamsters. J. Natl. Cancer Inst. Monogr. 1:1-59 (1959).
19. Nandi, S., Guzman, R.C., Yang, J. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc. Nat. Acad. Sci. USA 92:3650-3657 (1995).
20. Hou, X. Li, J.J., Chen, W.B., Li, S.A. Estrogen-induced protooncogene and suppressor gene expression in the hamster kidney: Significance for estrogen carcinogenesis. Cancer Res. 56:2616-2620 (1996).
21. Li, J.J., Papa, D., Davis, M.F., Weroha, S.J., Aldaz, M., El-Bayoumy, K, Ballenger, J., Tawfik, O., Li, S.A. Ploidy differences between hormone- and chemical carcinogen-induced mammary neoplasms: Relations to human breast cancer. Molec. Carcinogen. 33:56-65 (2002).
22. Chepko, G., Smith, G.H. Mammary epithelial stem cells: Our current understanding. J. Mammary Gland Biol. Neoplasia 4:35-52 (1999).
23. Li, J.J., Hou, X., Bentel, J.M., Yazlovitskaya, E.M., Li, S.A. Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: Some unique properties of a synthetic estrogen. Carcinogenesis 19:471-477 (1998).
24. Li, J.J., Weroha, S.J., Cansler, M, Li, S.A. Estrogen receptor-mediated genomic instability in the Syrian hamster kidney: A critical event in hormonal carcinogenesis. In: Hormonal Carcinogenesis III (Eds. Li, J.J., Daling, J.R., Li, S.A.), Springer-Verlag, New York, pp. 149-157 (2000).
25. Li, J.J., Papa, D., Li, S.A. Ectopic uterine stem cell tumors in the hamster kidney: A unique model for estrogen-induced oncogenesis. Minerva Endocrinol., in press (2003).
26. Li, J.J., Hou, X., Banerjee, S.K., Liao, D.J., Maggouta, F., Norrris, J.S., Li, S.A. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: A probable critical role in neoplastic transformation. Cancer Res. 59:2340-2346 (1999).
27. Felsher D.W., Bishop, J.M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Nat. Acad. Sci. USA 96:3940-3944 (1999).
28. Eilers, M., Picard, D., Yammamoto, K.R., Bishop, J.M. Chimaeras of MYC oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68 (1989).
29. Taylor, C., Jalava, A., Mai, S. c-Myc dependent initiation of genomic instability during neoplastic transformation. Curr. Top. Microbiol. Immunol. 224:201-207 (1997).
30. Yiu, X.Y., Grove L, Datta, N.S., Long, M.W., Prochownik, E.V. C-Myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18:1177-1184 (1999).